Researchers identified mechanisms that limit CD4+ Th1 cell differentiation during chronic viral infection. They discovered an intermediate precursor subset and showed that PD-1/PD-L1 signaling and the ...

Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.

In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite ...

An fresh look at trial results that propelled the only FDA approval of a chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma (MCL) shows prior treatment with ibrutinib, a ...

Researchers engineered CD4+ chimeric antigen receptor T cells targeting fibrillar amyloid beta and tested them in a mouse ...

Protein folding helpers such as TRiC and prefoldin (PFD) are crucial for the correct folding of many essential proteins. In a Nature study, researchers from the Max Planck Institute of Biochemistry ...

T cells help the body heal from injuries and fight infections. They do this by making proteins called anti-inflammatory cytokines that help wounds close, and recruiting or modifying other immune cells ...

Researchers found that butyrate, a microbial metabolite, enhances T-cell activity, thereby boosting IgA antibody production.

Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.

Scientists analyzing human and mouse pancreatic lymph nodes (PLNs) and spleens have identified a distinct subset of CD4 memory helper T cells associated with type 1 diabetes (T1D). Reported by ...